"Heterogeneity of Cytoskeletal Architecture as an Indicator of Treatment Response"
topic: investigate relationship between intra-cellular heterogeneity of biophysical measurements with therapeutic response to taxane-based therapy in patients with advanced prostate cancer.
joint project between four PSOCs: Moffitt, Scripps, Cornell and University of Southern California
SIAM Life Sciences, San Diego August 6-10 2012
PSOC Annual Meeting, Tampa April 16-18, 2012
"Optimising cell-cycle inhibitors in sarcomas: an integrative model"
topic: develop a computational model of cell-cycle targeted chemotherapies and investigate synergistic effects of drug combination therapies in various sarcomas
joint project between IMO and Moffitt Sarcoma Program